Pharma-Bio Serv, Inc.
PBSV
$0.55
$0.07515.79%
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 9.51M | 10.77M | 12.93M | 15.12M | 16.98M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.51M | 10.77M | 12.93M | 15.12M | 16.98M |
| Cost of Revenue | 6.99M | 8.05M | 9.30M | 10.76M | 11.91M |
| Gross Profit | 2.52M | 2.72M | 3.63M | 4.36M | 5.07M |
| SG&A Expenses | 3.80M | 3.90M | 3.98M | 4.01M | 3.95M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.80M | 11.96M | 13.28M | 14.77M | 15.86M |
| Operating Income | -1.29M | -1.19M | -343.00K | 350.50K | 1.12M |
| Income Before Tax | -755.40K | -788.40K | 89.30K | 854.60K | 1.69M |
| Income Tax Expenses | 22.10K | 52.40K | 94.60K | 241.40K | 377.20K |
| Earnings from Continuing Operations | -0.78 | -0.84 | -0.01 | 0.61 | 1.31 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -777.60K | -840.80K | -5.40K | 613.10K | 1.31M |
| EBIT | -1.29M | -1.19M | -343.00K | 350.50K | 1.12M |
| EBITDA | -1.26M | -1.16M | -311.40K | 389.70K | 1.17M |
| EPS Basic | -0.03 | -0.04 | 0.00 | 0.03 | 0.06 |
| Normalized Basic EPS | -0.02 | -0.02 | 0.00 | 0.02 | 0.05 |
| EPS Diluted | -0.03 | -0.04 | 0.00 | 0.03 | 0.06 |
| Normalized Diluted EPS | -0.02 | -0.02 | 0.00 | 0.02 | 0.05 |
| Average Basic Shares Outstanding | 91.86M | 91.88M | 91.89M | 91.89M | 91.87M |
| Average Diluted Shares Outstanding | 91.89M | 91.91M | 91.94M | 91.98M | 91.96M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -221.48% | -204.83% | -31,892.59% | 281.16% | 131.57% |
